![AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic
<i>IDH2</i>
Mutations]()
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic
<i>IDH2</i>
MutationsYen, Katharine; Travins, Jeremy; Wang, Fang; David, Muriel D.; Artin, Erin; Straley, Kimberly; Padyana, Anil; Gross, Stefan; DeLaBarre, Byron; Tobin, Erica; Chen, Yue; Nagaraja, Raj; Choe, Sung; Jin, Lei; Konteatis, Zenon; Cianchetta, Giovanni; Saunders, Jeffrey O.; Salituro, Francesco G.; Quivoron, Cyril; Opolon, Paule; Bawa, Olivia; Saada, Véronique; Paci, Angelo; Broutin, Sophie; Bernard, Olivier A.; de Botton, Stéphane; Marteyn, Benoît S.; Pilichowska, Monika; Xu, YingXia; Fang, Cheng; Jiang, Fan; Wei, Wentao; Jin, Shengfang; Silverman, Lee; Liu, Wei; Yang, Hua; Dang, Lenny; Dorsch, Marion; Penard-Lacronique, Virginie; Biller, Scott A.; Su, Shin-San Michael · Cancer Discovery · 2017